Claims
- 1. Quinoline derivatives according to the formula 1
- 2. A therapeutic method for treating tumors in mammals, which comprises administering to a mammal in need therefor at least one quinoline derivative of claim 1 in a tumor treatment effective dose.
- 3. A medicament which comprises as active ingredient at least one quinoline derivative according of claim 1, together with conventional pharmaceutically acceptable auxiliaries, additives and carriers.
- 4. The pharmaceutically acceptable acid addition salt of the quinoline derivative of claim 1, when formed with one of the acids hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, fumaric acvid, succinic acid, lactic acid, citric acid, acetic acid, tartaric acid, malic acid, maleic acid, embonic acid, malonic acid, trifluoroacetic acid, metanesulfonic acid, and sulfoacetic acid.
Priority Claims (1)
Number |
Date |
Country |
Kind |
100 35 928.0 |
Jul 2000 |
DE |
|
RELATED APPLICATION
[0001] This application is a continuation of co-pending application Ser. No. 09/910,141 filed Jul. 20, 2001.
Continuations (1)
|
Number |
Date |
Country |
Parent |
09910141 |
Jul 2001 |
US |
Child |
10741310 |
Dec 2003 |
US |